tiprankstipranks
Trending News
More News >
Serstech AB (SE:SERT)
:SERT

Serstech AB (SERT) AI Stock Analysis

Compare
0 Followers

Top Page

SE

Serstech AB

(Frankfurt:SERT)

Rating:47Neutral
Price Target:
Serstech AB's overall stock score is 47, reflecting a challenging financial position with declining revenues and persistent net losses. The strong balance sheet provides some stability, but cash flow management needs improvement. The technical analysis suggests a neutral to slightly bearish trend, and the stock's valuation is hampered by a negative P/E ratio and lack of dividend yield. Overall, the company needs to enhance revenue growth and profitability to improve its stock performance.

Serstech AB (SERT) vs. iShares MSCI Sweden ETF (EWD)

Serstech AB Business Overview & Revenue Model

Company DescriptionSerstech AB (SERT) is a Swedish company specializing in the development and manufacture of portable chemical identification instruments. These devices are designed to enhance safety and security by allowing for the rapid identification of hazardous materials, drugs, and explosives in various environments. Serstech's products are predominantly used by law enforcement, military, and emergency response teams across the globe, making them a pivotal player in the sectors of safety and security technology.
How the Company Makes MoneySerstech AB generates revenue primarily through the sale of its handheld chemical identification devices. The company offers comprehensive solutions that include both hardware and accompanying software, which enable seamless integration and data management. Apart from direct sales, Serstech also engages in service contracts and maintenance agreements, providing ongoing support and updates to its clients. Partnerships with governmental agencies and collaborations with international distributors further expand their market reach, contributing significantly to their earnings. Additionally, Serstech frequently participates in public tenders, securing contracts that bolster its revenue stream.

Serstech AB Financial Statement Overview

Summary
Serstech AB faces challenges in achieving profitability, as reflected in its income statement with declining revenues and persistent net losses. The balance sheet is strong, showing low financial leverage and a high equity ratio, which provides stability. Cash flow management shows room for improvement, with negative free cash flow trends. While the company demonstrates financial resilience, efforts to enhance revenue growth and profitability are crucial for future success.
Income Statement
45
Neutral
Serstech AB shows a mixed performance in its income statement. The gross profit margin is relatively healthy, but there is a significant decline in total revenue from 2023 to 2024, indicating a negative revenue growth rate. Additionally, the company has consistently reported net losses, leading to a negative net profit margin. The absence of positive EBIT and negative EBITDA margin further reflect challenges in operational profitability.
Balance Sheet
60
Neutral
The balance sheet indicates a strong equity position with an impressive equity ratio, suggesting financial stability. The company has eliminated its total debt, reducing financial risk. However, the return on equity is negative due to ongoing net losses, and this remains a concern for profitability and return for shareholders.
Cash Flow
50
Neutral
Cash flow analysis reveals a decline in operating cash flow compared to previous years, yet the company maintains a significant cash reserve. The free cash flow remains negative, indicating cash outflows exceed inflows, primarily due to substantial capital expenditures. The operating cash flow to net income ratio is positive, showing better cash generation relative to net income losses.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
57.98M52.26M62.91M17.11M18.65M20.49M
Gross Profit
40.57M38.33M48.59M12.93M15.53M18.22M
EBIT
-11.05M-9.04M-1.25M-29.28M-10.68M-6.54M
EBITDA
-1.83M-1.14M12.98M-21.24M-9.77M-6.18M
Net Income Common Stockholders
-9.86M-9.13M715.00K-29.57M-10.25M-6.73M
Balance SheetCash, Cash Equivalents and Short-Term Investments
42.07M9.29M18.47M1.87M19.57M11.40M
Total Assets
90.43M94.72M59.71M52.55M66.56M56.25M
Total Debt
0.000.001.80M4.74M1.70M2.82M
Net Debt
-19.07M-9.29M-16.67M2.87M-17.88M-8.58M
Total Liabilities
15.28M18.16M11.74M25.93M10.45M12.38M
Stockholders Equity
75.15M76.56M47.97M26.62M56.11M43.87M
Cash FlowFree Cash Flow
-11.27M-8.49M-1.37M-20.75M-13.19M-10.75M
Operating Cash Flow
-4.23M562.00K7.63M-13.16M-628.00K3.56M
Investing Cash Flow
-31.12M-7.95M-9.00M-7.59M-12.55M-14.31M
Financing Cash Flow
36.48M-1.80M17.98M3.04M21.36M6.99M

Serstech AB Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.68
Price Trends
50DMA
0.76
Negative
100DMA
0.88
Negative
200DMA
1.01
Negative
Market Momentum
MACD
-0.03
Positive
RSI
37.55
Neutral
STOCH
11.34
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:SERT, the sentiment is Negative. The current price of 0.68 is below the 20-day moving average (MA) of 0.72, below the 50-day MA of 0.76, and below the 200-day MA of 1.01, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 37.55 is Neutral, neither overbought nor oversold. The STOCH value of 11.34 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:SERT.

Serstech AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (60)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
60
Neutral
kr34.37B-7.550.97%13.43%12.43%17.85%
59
Neutral
kr171.43M-27.73%373.74%46.13%
52
Neutral
€302.63M-5.94%2.29%45.77%
47
Neutral
€172.68M-15.65%-10.46%-680.00%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:SERT
Serstech AB
0.68
-1.09
-61.64%
SE:AXIC.A
aXichem AB Class A
2.90
1.63
128.35%
SE:NEXAM
Nexam Chemical Holding AB
3.74
0.50
15.43%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.